Long-Term Sulfonylurea Use and Impaired Awareness of Hypoglycemia Among Patients With Type 2 Diabetes in Taiwan

被引:0
|
作者
Cheng, Hsiang-Ju [1 ]
Weng, Siou-Huei [2 ,3 ]
Wu, Jia-Ling [2 ]
Yeh, Shu-Tin [4 ]
Chen, Hua-Fen [4 ,5 ,6 ]
Novida, Hermina [7 ]
Ou, Huang-Tz [8 ,9 ,10 ]
Li, Chung-Yi [2 ,11 ,12 ]
机构
[1] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Family Med, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, 1 Univ Rd, Tainan 701, Taiwan
[3] Tainan City Govt, Publ Hlth Bur, Dis Control Sect Div, Tainan, Taiwan
[4] Far Eastern Mem Hosp, Dept Endocrinol, New Taipei City, Taiwan
[5] Fu Jen Catholic Univ, Coll Med, Dept Med, New Taipei City, Taiwan
[6] Fu Jen Catholic Univ, Coll Med, Dept Publ Hlth, New Taipei City, Taiwan
[7] Univ Airlangga, Fac Med, Dept Internal Med, Div Endocrine Metab & Diabet, Surabaya, Indonesia
[8] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Coll Med, Tainan, Taiwan
[9] Natl Cheng Kung Univ, Coll Med, Dept Pharm, Tainan, Taiwan
[10] Natl Cheng Kung Univ Hosp, Dept Pharm, Tainan, Taiwan
[11] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan
[12] Asia Univ, Coll Med & Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan
关键词
hypoglycemia; type; 2; diabetes; sulfonylurea; insulin; hypoglycemic agents; glycemic control; risk factors; diabetes complications; primary care; MECHANISMS; FREQUENCY;
D O I
10.1370/afm.3129
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
PURPOSE We undertook a study to investigate the relationship between duration of medication use and prevalence of impaired awareness of hypoglycemia (IAH) among patients with insulin-treated or sulfonylurea-treated type 2 diabetes in Taiwan. METHODS A total of 898 patients (41.0% insulin users, 65.1% sulfonylurea users; mean [SD] age = 59.9 [12.3] years, 50.7% female) were enrolled in pharmacies, clinics, and health bureaus of Tainan City, Taiwan. Presence of IAH was determined with Chinese versions of the Gold questionnaire (Gold-TW) and Clarke questionnaire (Clarke-TW). Sociodemographics, disease and treatment histories, diabetes-related medical care, and health status were collected. We used multiple logistic regression models to assess the relationship between duration of medication use and IAH. RESULTS Overall IAH prevalence was 41.0% (Gold-TW) and 28.2% (Clarke-TW) among insulin users, and 65.3% (Gold-TW) and 51.3% (Clarke-TW) among sulfonylurea users. Prevalence increased with the duration of sulfonylurea use, whereas it decreased with the duration of insulin use. After controlling for potential confounders, 5 or more years of sulfonylurea use was significantly associated with 3.50-fold (95% CI, 2.39-5.13) and 3.06-fold (95% CI, 2.114.44) increases in the odds of IAH based on the Gold-TW and Clarke-TW criteria, respectively. On the other hand, regular blood glucose testing and retinal examinations were associated with reduced odds in both insulin users and sulfonylurea users. CONCLUSIONS The prevalence of IAH was high among patients using sulfonylureas long term, but the odds of this complication were attenuated for those who received regular diabetes-related medical care. Our study suggests that long-term sulfonylurea use and irregular follow-up increase risk for IAH. Further prospective studies are needed to confirm the observed associations. Ann Fam Med 2024;22:309-316. https://doi.org/10.1370/afm.3129 Annals Early Access article
引用
收藏
页码:309 / 316
页数:8
相关论文
共 50 条
  • [41] A Simulation of the Comparative Long-term Effectiveness of Liraglutide and Glimepiride Monotherapies in Patients with Type 2 Diabetes Mellitus
    Sullivan, Sean D.
    Alfonso-Cristancho, Rafael
    Conner, Chris
    Hammer, Mette
    Blonde, Lawrence
    PHARMACOTHERAPY, 2009, 29 (11): : 1280 - 1288
  • [42] Bolus Calculator Reduces Hypoglycemia in the Short Term and Fear of Hypoglycemia in the Long Term in Subjects with Type 1 Diabetes (CBMDI Study)
    Vallejo Mora, Maria del Rosario
    Carreira, Monica
    Teresa Anarte, Maria
    Linares, Francisca
    Olveira, Gabriel
    Gonzalez Romero, Stella
    DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (07) : 402 - 409
  • [43] Hypoglycemia Among Type 1 Diabetes Patients After Insulin Use in Southwest Ethiopia
    Yosef, Tewodros
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [44] Effect of short-term use of dapagliflozin on impaired awareness of hypoglycaemia in people with type 1 diabetes
    van Meijel, Lian A.
    Tack, Cees J.
    de Galan, Bastiaan E.
    DIABETES OBESITY & METABOLISM, 2021, 23 (11): : 2582 - 2589
  • [45] Long-term Effect of Biomineralized Insulin Nanoparticles on Type 2 Diabetes Treatment
    Xiao, Yun
    Wang, Xiaoyu
    Wang, Ben
    Liu, Xueyao
    Xu, Xurong
    Tang, Ruikang
    THERANOSTICS, 2017, 7 (17): : 4301 - 4312
  • [46] Association between hypoglycemia and dementia in patients with type 2 diabetes
    Sheen, Yi-Jing
    Sheu, Wayne H. H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 116 : 279 - 287
  • [47] Interoceptive Awareness Is Associated With Impaired Awareness of Hypoglycemia in Adults With Type 1 Diabetes
    Matus, Austin M.
    Riegel, Barbara
    Rickels, Michael R.
    DIABETES CARE, 2025, 48 (01)
  • [48] Investigation of Eating Disorders and Hypoglycemia Awareness in People with Type 2 Diabetes
    Kodaz, Lutfiye
    Karaman, Sibel TUNc
    Basat, Okcan
    NAMIK KEMAL MEDICAL JOURNAL, 2024, 12 (04): : 252 - 259
  • [49] Long-Term Survivor Characteristics in Hemodialysis Patients with Type 2 Diabetes
    Triebswetter, Susanne
    Gutjahr-Lengsfeld, Lena J.
    Schmidt, Kay-Renke
    Drechsler, Christiane
    Wanner, Christoph
    Krane, Vera
    AMERICAN JOURNAL OF NEPHROLOGY, 2018, 47 (01) : 30 - 39
  • [50] Long-term glycaemic control with pioglitazone in patients with type 2 diabetes
    Campbell, IW
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (02) : 192 - 200